News

Natural Products Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, Maryland 21702-1201, United States Molecular Targets ...
Edited by James A. Birchler, University of Missouri-Columbia, Columbia, MO, and approved April 18, 2014 (received for review October 11, 2013) Numbers indicate genes with at least four supporting SNPs ...
Living in a flat or house without a garden often leaves little room for cultivating beautiful flowers and delicious ...
MSD Animal Health has been granted the marketing authorisation in the UK for Bravecto Triuno, a new formulation of Bravecto (fluralaner) for dogs that targets both external and internal parasites.